Purchase Order 75N92E25P00158
Award Date
5/7/25
Potential Completion Date
8/31/25
Potential Value
$20K
Federal Agency
National Human Genome Research Institute
Awardee
Ultima Genomics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.025 million firm-fixed-price purchase order contract to Ultima Genomics, Inc. of Newark, California. Under the terms of the contract, Ultima Genomics will provide one of its UG100-V DNA sequencers to the NIH's Vaccine Research Center in Bethesda, Maryland by March 19, 2023. The sequencer will support high-throughput next-generation sequencing capabilities,...
This federal contract award to Illumina, Inc. is a delivery order valued at $35,935.00 for the provision of genomic sequencing systems, reagents, and related services. The award was made by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), a civilian agency. The contract is a firm fixed price arrangement with no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments, has received numerous prior...
This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $149,627.88, was awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract is a delivery order and is a firm fixed-price arrangement, with no set-aside designation. Illumina has previously provided a range of sequencing systems, reagents,...
This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $498,777.14 contract is to provide Illumina sequencing systems, reagents, and services to support genomic sequencing and analysis for NHGRI's research and diagnostic needs. Illumina has been awarded multiple federal contracts and sub-grants by agencies such as the National...
This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc. for $17,149.00. The award is not associated with a set-aside program. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously received prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide sequencing platforms, consumables, and services...
This federal contract award, valued at $207,840.00, was issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Agena Bioscience, Inc., a for-profit corporation that provides genomic testing equipment, reagents, and services. The contract is a firm fixed price purchase order with no set-aside designation. Agena Bioscience has previously received federal contracts from agencies such as the Centers for Disease Control and...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Illumina, Inc. for $16,447.05. The contract is for the provision of reagents needed by NHGRI staff scientists for preparation of PCR-free whole genome libraries and sequencing. The contract has a period of performance through March 31, 2025 and does not have a set-aside designation. Illumina, a for-profit manufacturer of genomic sequencing instruments and reagents, has...
This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc. for $499,993.60. The award is not associated with a set-aside program. Illumina is providing a range of sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis for NHGRI research and diagnostic applications. Illumina has previously received prime federal contracts and...
This federal contract was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis equipment and reagents. The $135,680.40 firm fixed price contract is for the delivery of Illumina's sequencing systems, reagents, and related services to support genomic research and analysis across various government agencies. The award has no set-aside designation. Illumina has...